Scotiabank analyst Sung Ji Nam initiated coverage of Myriad Genetics with an Outperform rating and $29 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYGN:
- Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election
- Myriad Genetics announces collaboration with GSK
- Myriad Genetics launches new Universal Plus Panel for Foresight Carrier Screen
- Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen
- Myriad Genetics Proposes Settlement in Shareholder Lawsuits